Free Republic

Former FDA Commissioner Dr. Scott Gottlieb said Sunday that a COVID-19 vaccine for children age 4 and under could be approved by early March. Gottlieb said the authorization would depend on whether federal officials move forward with Pfizer’s two-dose candidate, as opposed to the three-dose one added last month to the company’s clinical trials. The two-dose shot could presumably be approved the fastest of the two, since trials on it are further ahead, so it’s just a question of whether its potency is considered enough protection for the age group at this point, Gottlieb said.